Situations of MTC in individuals handled with liraglutide, Yet another GLP-one receptor agonist, have been documented during the postmarketing interval; the data in these experiences are insufficient to establish or exclude a causal relationship involving MTC and GLP-1 receptor agonist use in people. Tell people of the likely hazard for cholelit